EPI-321

Epicrispr Biotechnologies, Inc. · Phase 1 active Biologic

At a glance

Generic name	EPI-321
Sponsor	Epicrispr Biotechnologies, Inc.
Modality	Biologic
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

EPI-321 CI brief — competitive landscape report
EPI-321 updates RSS · CI watch RSS
Epicrispr Biotechnologies, Inc. portfolio CI